Research carried out over the last few decades has revealed the multifaceted pharmacological effects of forskohlin.
Most of these effects have been linked to the role of forskohlin as an activator of adenylate cyclase1.
Normally, cAMP is formed when a stimulatory hormone (e.g., epinephrine) binds to a receptor site on
the cell membrane and triggers the activation of adenylate cyclase.
The receptors on each cell are specific to the activating hormone.
Forskohlin appears to bypass the hormone-receptor interactions and activates adenylate cyclase. Adenylate cyclase activation induces a rise in intracellular cAMP levels2.
Sabinsa Wins Again: Federal Court Denies Creative Compounds Motion
Listen to a brief video on ForsLean®
View past and recent advertisements
Innovative Ingredients Paper Weight loss approach
Sabinsa calls to readers' attention that some of the products, protocols and uses of the products described here in are or may be subject to various restrictions or limitations because of patents, exclusive or nonexclusive licenses, confidentiality agreements and other intellectual property or equivalent rights. Readers are advised to make an early and thorough investigation and inquiry into any product, protocol or use in which they may be interested, to see if any such rights might be applicable. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.